查看更多>>摘要:By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Artificial Intelligenc e is the subject of a report. According to news reporting originating from Ankar a, Turkey, by NewsRx correspondents, research stated, "Oncology is the primary f ield in medicine with a high rate of artificial intelligence (AI) use. Thus, thi s study aimed to investigate the trends of AI in oncology, evaluating the biblio graphic characteristics of articles." Financial support for this research came from Turkiye Bilimsel ve Teknolojik Ara stirma Kurumu. Our news editors obtained a quote from the research from Baskent University, "We evaluated the related research on the knowledge framework of Artificial Intelli gence (AI) applications in Oncology through bibliometrics analysis and explored the research hotspots and current status from 1992 to 2022. The research employe d a scientometric methodology and leveraged scientific visualization tools such as Bibliometrix R Package Software, VOSviewer, and Litmaps for comprehensive dat a analysis. Scientific AI-related publications in oncology were retrieved from t he Web of Science (WoS) and InCites from 1992 to 2022. A total of 7,815 articles authored by 35,098 authors and published in 1,492 journals were included in the final analysis. The most prolific authors were Esteva A (citaition = 5,821) and Gillies RJ (citaition = 4288). The most active institutions were the Chinese Ac ademy of Science and Harward University. The leading journals were Frontiers in Oncology and Scientific Reports. The most Frequent Author Keywords are ‘machine learning', ‘deep learning,' ‘radiomics', ‘breast cancer', ‘melanoma' and ‘artifi cial intelligence,' which are the research hotspots in this field. A total of 10 ,866 Authors' keywords were investigated. The average number of citations per do cument is 23. After 2015, the number of publications proliferated. The investiga tion of Artificial Intelligence (AI) applications in the field of Oncology is st ill in its early phases especially for genomics, proteomics, and clinicomics, wi th extensive studies focused on biology, diagnosis, treatment, and cancer risk a ssessment. This bibliometric analysis offered valuable perspectives into AI's ro le in Oncology research, shedding light on emerging research paths. Notably, a s ignificant portion of these publications originated from developed nations."